UBIO
Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO
Delisted
UBIO was delisted on the 27th of March, 2020.
9 hedge funds and large institutions have $4.17M invested in Proshares UltraPro NASDAQ Biotechnology in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+3
Holders Change %
+50%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
2
Closed
–
Calls
$680K
Puts
–
Net Calls
+$680K
Net Calls Change
+$947K
Top Buyers
| 1 |
Jane Street
New York
|
+$1.79M |
| 2 |
VF
Virtu Financial
New York
|
+$422K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$310K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$286K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$68K |
Top Sellers
| 1 |
CG
Cutler Group
San Francisco,
California
|
-$9K |
| 2 |
Morgan Stanley
New York
|
-$33 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $1.79M | +$1.79M | +53,809 | New |
|
|
VF
2
Virtu Financial
New York
| $1.18M | +$422K | +12,703 | +56% |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $790K | +$310K | +9,331 | +65% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $286K | +$286K | +8,641 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $68K | +$68K | +2,045 | New |
|
|
6
Morgan Stanley
New York
| $30K | -$33 | -1 | -0.1% |
|
|
LTFS
7
Ladenburg Thalmann Financial Services
Miami,
Florida
| $23K | – | – | – |
|
|
AIM
8
Anchor Investment Management
Columbia,
South Carolina
| $9.12K | – | – | – |
|
|
CG
9
Cutler Group
San Francisco,
California
| $3K | -$9K | -300 | -75% |
|